Skip to Content


In the US, Clofarabine (clofarabine systemic) is a member of the drug class antimetabolites and is used to treat Acute Lymphoblastic Leukemia.

US matches:

UK matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories



Cytostatic agent: Antimetabolite

Chemical Names


2-Chlor-9-(2-desoxy-2-fluor-beta-D-arabinofuranosyl)purin-6-amin (IUPAC)

2-Chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-9H-purin-6-amine (WHO)

9H-Purin-6-amine, 2-chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)- (USAN)

Foreign Names

  • Clofarabinum (Latin)
  • Clofarabin (German)
  • Clofarabine (French)
  • Clofarabina (Spanish)

Generic Names

  • Clofarabine (OS: USAN, BAN, JAN)
  • C1-F-Ara-A (IS)
  • CAfdA (IS)
  • Clofarex (IS)
  • Clolar (IS)

Brand Names

  • Clofazic
    Raffo, Argentina
  • Clofazic (Clofarabine and Sodium Chloride)
    Tecnofarma, Chile
  • Clolar
    Genzyme, United States; sanofi-aventis, Canada
  • Evoltra
    Genzyme, Belgium; Genzyme, Czech Republic; Genzyme, Germany; Genzyme, Greece; Genzyme, Israel; Genzyme, Italy; Genzyme, Lithuania; Genzyme, Norway; Genzyme, Poland; Genzyme, Romania; Genzyme Europe, Austria; Genzyme Europe, Cyprus; Genzyme Europe, Slovenia; Hospira, Australia; Hospira, New Zealand; Penn Pharmaceutical, Latvia; Sanofi, Germany; Sanofi, United Kingdom; Sanofi, Ireland; Sanofi, Japan; Sanofi, Sweden; Sanofi Aventis, Spain; Sanofi-Aventis, Bosnia & Herzegowina; Sanofi-Aventis, Denmark; Sanofi-Aventis, France; Sanofi-Aventis, Hong Kong; Sanofi-Aventis, Malaysia; Sanofi-Aventis, Singapore; Sanofi-Aventis, Thailand
  • Folotyn
    Mundipharma, Singapore


BANBritish Approved Name
IUPACInternational Union of Pure and Applied Chemistry
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.